AG
CLSD

Algert Global’s Clearside Biomedical CLSD Stock Holding History

Algert Global’s Portfolio CLSD Stock Details CLSD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-1,287
Closed -$28K – 1191
2022
Q2 		$28K Buy
1,287
+260
+25% +$6.31K ﹤0.01% 1170
2022
Q1 		$35K Buy
+1,027
New +$30.7K ﹤0.01% 1151
2020
Q2 		– Sell
-1,695
Closed -$43K – 431
2020
Q1 		$43K Buy
+1,695
New +$62.7K 0.02% 386

Other funds holding CLSD

CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
ACM
ACT Capital Management Wayne, Pennsylvania $127M AUM
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Algert Global's CLSD Position: Q3 2022 in Review

Algert Global sold out of Clearside Biomedical (CLSD) in Q3 2022, closing a stake of 1,287 shares — an estimated $28K sold.

Algert Global first reported a position in CLSD in Q1 2020 and held it in 3 quarters. The position peaked at $43K in Q1 2020. 54 funds tracked by Wall St. Rank hold CLSD as of Q3 2022.

  • Algert Global reported no remaining Clearside Biomedical position as of Q3 2022 after selling out during the quarter.
  • Algert Global sold 1,287 Clearside Biomedical shares in Q3 2022, an estimated $28K.
  • Algert Global first reported a position in Clearside Biomedical in Q1 2020 and held it in 3 quarters.
  • Algert Global's Clearside Biomedical position peaked at $43K in Q1 2020.
  • 54 funds tracked by Wall St. Rank held Clearside Biomedical as of Q3 2022.

Based on Algert Global's 13F filing for Q3 2022, filed 15 Nov 2022.